SPEAKING · KEYNOTES · EXPERT PERSPECTIVES
Evidence-led. Practice-informed. Patient-centred. I bring a distinct voice to the questions shaping HEOR and market access.
FROM PRODUCT TO PATIENT
88 seconds · the kind of thinking I bring to the stage
CONVERSATIONS WORTH HAVING
Five topics, each adaptable to a keynote, a panel or a hands-on session. Every talk draws on 14 years across Pharma and MedTech and real access work in Europe and beyond.
Why proving value is only the beginning — and how reimbursement categories, decision frameworks and implementation shape what reaches patients.
For: Leadership, Market Access, Commercial
Patient need, quality of life and societal impact. A critical look at what HEOR and SROI can illuminate — and what decision-makers still need to consider.
For: HEOR, Medical, policy and patient organisations
What AI changes in HEOR, and what it cannot replace: context, judgement, meaningful questions and responsibility for the interpretation.
For: HEOR and evidence teams, conferences
JCA and the European evidence landscape: shared clinical assessment is not a shared reimbursement decision.
For: Pharma and MedTech leadership, Market Access
How to turn a product, a set of markets and a pile of evidence into a sequenced access plan with owners, stakeholders and roadblocks named.
For: Cross-functional launch and access teams
FORMATS
One clear argument, built for a conference or company event.
A grounded voice on HEOR, access and policy questions.
Leadership framed around the access decision ahead.
The frameworks applied to your product, market and evidence.
Every talk is tailored to your audience. Formats and lengths are indicative; nothing is booked until we have agreed date, scope and fee.
MY CONVICTION
More evidence is not the goal
Better decisions are
A strategic perspective grounded in 14 years across Pharma and MedTech,
international market experience and a legal foundation.